Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · NZK

Stimulator, Low Electric Field, Tumor Treatment

Intended to treat tumors by application of low electic fields and indicated for treatment of recurrent glioblastoma multiforme (gbm) in patients who have received maximum standard therapy with continued disease progress, as defined by tumor growth or decline in neurological status.

Product / regulatory recordCompanyPathwayDecision dateSource
Novocure, GmbHPMA supplementSep 18, 2026FDA
Novocure, GmbHPMA supplementSep 16, 2026FDA
Optune GioP100034/S042
Novocure, GmbHPMA supplementJun 4, 2026FDA
Novocure, GmbHPMA supplementApr 9, 2026FDA
Optune GioP100034/S043
Novocure, GmbHPMA supplementFeb 25, 2026FDA
Novocure, GmbHPMA supplementOct 23, 2025FDA
Novocure, GmbHPMA approvalApr 8, 2011FDA
Source information

Follow the FDA links to view the original records.

All device categories